Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Light Shed On Ways Circadian Disruption Affects Human Health
http://www.medicalnewstoday.com/articles/115370.php
Growing evidence indicates that exposure to irregular patterns of light and darkness can cause the human circadian system to fall out of synchrony with the 24-hour solar day, negatively affecting human health - but scientists have been unable to effectively study the relationship between circadian disruptions and human maladies.
Study Of 31 Countries Finds Wide Variations In Cancer Survival Rates
http://www.medicalnewstoday.com/articles/115086.php
A large study published in <i>The Lancet Oncology</i> has found that there are wide variations in cancer survival rates between and within many countries around the world. Professor Michel Coleman (Cancer Research UK Cancer Survival Group and London School of Hygiene and Tropical Medicine) and over 100 colleagues working on the CONCORD study analyzed 31 countries that provided data on cancer survival.
----------------------------------------------
** CANCER / ONCOLOGY News **
Researchers Find Better Way To Identify Melanoma
http://www.medicalnewstoday.com/articles/115493.php
University of Rochester Medical Center researchers found a new protein produced excessively in malignant melanoma, a discovery that is particularly relevant as skin cancer rates climb dramatically among young women.
Bradmer Reports Progression Free Survival Data From Previous Phase II Glioblastoma Multiforme Trials
http://www.medicalnewstoday.com/articles/115419.php
Bradmer Pharmaceuticals Inc. (TSX: BMR), a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, released progression free survival (PFS) data from two previously conducted Phase II trials of Neuradiab(TM) in glioblastoma multiforme (GBM) patients.
New Research From Rhode Island Hospital May Help Predict Outcomes For Stomach Cancer Patients
http://www.medicalnewstoday.com/articles/115374.php
Researchers at Rhode Island Hospital have identified two potential molecular markers that may predict outcomes for patients with stomach cancer, one of the most common and fatal cancers worldwide.
Researchers Target Specific Genes, Reduce Cancer Cells
http://www.medicalnewstoday.com/articles/115255.php
A report published on July 18 in the open-access journal <i>PLoSGenetics</i> describes a new approach to fighting cancer.Researchers have located a new type of ultrasensitive genes that seemto control the way cancer expresses itself (cancer-associatedphenotypes).
Study Of 31 Countries Finds Wide Variations In Cancer Survival Rates
http://www.medicalnewstoday.com/articles/115086.php
A large study published in <i>The Lancet Oncology</i> has found that there are wide variations in cancer survival rates between and within many countries around the world. Professor Michel Coleman (Cancer Research UK Cancer Survival Group and London School of Hygiene and Tropical Medicine) and over 100 colleagues working on the CONCORD study analyzed 31 countries that provided data on cancer survival.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Most Adults Don't Realize Activity Lowers Colon Cancer Risk
http://www.medicalnewstoday.com/articles/115430.php
Many experts now consider colon cancer a largely preventable disease, but a new study finds that primary care doctors might not always inform patients about one important step they can take to reduce their risk: becoming more physically active.
----------------------------------------------
** LUNG CANCER News **
BioNumerik Pharmaceuticals Observes Evidence Of A Survival Increase In Lung Cancer Patients Participating In Tavocept(TM) Clinical Trial
http://www.medicalnewstoday.com/articles/115415.php
BioNumerik Pharmaceuticals, Inc. ("BioNumerik") announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer) participating in a Phase II clinical trial of Tavocept(TM) showed a survival increase of approximately 198 days (6.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment